Elevation Oncology Inc Financial Flexibility Index
Elevation Oncology Inc financial flexibility index. Elevation Oncology Inc (ELEV) has a Financial Flexibility Index of -0.36x as of March 2025. Free cash flow of $-12.71 Million (operating CF $-12.71 Million minus capex $0.00) represents 0% of total liabilities ($35.49 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Elevation Oncology Inc (2019–2024)
Financial flexibility index of Elevation Oncology Inc from 2019 to 2024. Historical Financial Flexibility Index trend for Elevation Oncology Inc across 6 annual periods. Explore Elevation Oncology Inc (ELEV) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Elevation Oncology Inc Financial Flexibility Index by Year (2019–2024)
Elevation Oncology Inc financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for Elevation Oncology Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Elevation Oncology Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.02x | $-36.36 Million | $-36.36 Million | $35.60 Million | ▲ +37.7% |
| 2023 | -1.64x | $-56.18 Million | $-56.18 Million | $34.28 Million | ▲ +13.4% |
| 2022 | -1.89x | $-85.40 Million | $-85.48 Million | $45.13 Million | ▲ +44.7% |
| 2021 | -3.42x | $-30.08 Million | $-30.17 Million | $8.80 Million | ▼ -2808.2% |
| 2020 | -0.12x | $-12.23 Million | $-12.30 Million | $103.99 Million | ▲ +83.0% |
| 2019 | -0.69x | $-5.38 Million | $-5.45 Million | $7.79 Million | — |